Global Opioid Induced Constipation (OIC) Drug Market Research Report 2023

Report ID: 1995868 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Opioid Induced Constipation (OIC) Drug Market Overview
    1.1 Product Overview and Scope of Opioid Induced Constipation (OIC) Drug
    1.2 Opioid Induced Constipation (OIC) Drug Segment by Type
        1.2.1 Global Opioid Induced Constipation (OIC) Drug Market Value Comparison by Type (2023-2029)
        1.2.2 Lubiprostone
        1.2.3 Methyl Naltrexone Bromide
        1.2.4 Naldemedine
        1.2.5 Alvimopan
        1.2.6 Other
    1.3 Opioid Induced Constipation (OIC) Drug Segment by Distribution Channel
        1.3.1 Global Opioid Induced Constipation (OIC) Drug Market Value by Distribution Channel: (2023-2029)
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Global Opioid Induced Constipation (OIC) Drug Market Size Estimates and Forecasts
        1.4.1 Global Opioid Induced Constipation (OIC) Drug Revenue 2018-2029
        1.4.2 Global Opioid Induced Constipation (OIC) Drug Sales 2018-2029
        1.4.3 Global Opioid Induced Constipation (OIC) Drug Market Average Price (2018-2029)
    1.5 Assumptions and Limitations
2 Opioid Induced Constipation (OIC) Drug Market Competition by Manufacturers
    2.1 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Opioid Induced Constipation (OIC) Drug Average Price by Manufacturers (2018-2023)
    2.4 Global Opioid Induced Constipation (OIC) Drug Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Opioid Induced Constipation (OIC) Drug, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Opioid Induced Constipation (OIC) Drug, Product Type & Application
    2.7 Opioid Induced Constipation (OIC) Drug Market Competitive Situation and Trends
        2.7.1 Opioid Induced Constipation (OIC) Drug Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Opioid Induced Constipation (OIC) Drug Players Market Share by Revenue
        2.7.3 Global Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Opioid Induced Constipation (OIC) Drug Retrospective Market Scenario by Region
    3.1 Global Opioid Induced Constipation (OIC) Drug Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Opioid Induced Constipation (OIC) Drug Global Opioid Induced Constipation (OIC) Drug Sales by Region: 2018-2029
        3.2.1 Global Opioid Induced Constipation (OIC) Drug Sales by Region: 2018-2023
        3.2.2 Global Opioid Induced Constipation (OIC) Drug Sales by Region: 2024-2029
    3.3 Global Opioid Induced Constipation (OIC) Drug Global Opioid Induced Constipation (OIC) Drug Revenue by Region: 2018-2029
        3.3.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Region: 2018-2023
        3.3.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Region: 2024-2029
    3.4 North America Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Country
        3.4.1 North America Opioid Induced Constipation (OIC) Drug Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Opioid Induced Constipation (OIC) Drug Sales by Country (2018-2029)
        3.4.3 North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2018-2029)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Country
        3.5.1 Europe Opioid Induced Constipation (OIC) Drug Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2018-2029)
        3.5.3 Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Country
        3.6.1 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Country (2018-2029)
        3.6.3 Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
        3.6.13 Philippines
    3.7 Latin America Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Country
        3.7.1 Latin America Opioid Induced Constipation (OIC) Drug Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Opioid Induced Constipation (OIC) Drug Sales by Country (2018-2029)
        3.7.3 Latin America Opioid Induced Constipation (OIC) Drug Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Country
        3.8.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 U.A.E
4 Segment by Type
    4.1 Global Opioid Induced Constipation (OIC) Drug Sales by Type (2018-2029)
        4.1.1 Global Opioid Induced Constipation (OIC) Drug Sales by Type (2018-2023)
        4.1.2 Global Opioid Induced Constipation (OIC) Drug Sales by Type (2024-2029)
        4.1.3 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2018-2029)
    4.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2018-2029)
        4.2.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2018-2023)
        4.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2024-2029)
        4.2.3 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2018-2029)
    4.3 Global Opioid Induced Constipation (OIC) Drug Price by Type (2018-2029)
5 Segment by Distribution Channel
    5.1 Global Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2018-2029)
        5.1.1 Global Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2018-2023)
        5.1.2 Global Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2024-2029)
        5.1.3 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2018-2029)
    5.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2018-2029)
        5.2.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2018-2023)
        5.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2024-2029)
        5.2.3 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2018-2029)
    5.3 Global Opioid Induced Constipation (OIC) Drug Price by Distribution Channel (2018-2029)
6 Key Companies Profiled
    6.1 Ironwood Pharmaceuticals
        6.1.1 Ironwood Pharmaceuticals Corporation Information
        6.1.2 Ironwood Pharmaceuticals Description and Business Overview
        6.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.1.5 Ironwood Pharmaceuticals Recent Developments/Updates
    6.2 Daiichi Sankyo Co
        6.2.1 Daiichi Sankyo Co Corporation Information
        6.2.2 Daiichi Sankyo Co Description and Business Overview
        6.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.2.5 Daiichi Sankyo Co Recent Developments/Updates
    6.3 Pfizer
        6.3.1 Pfizer Corporation Information
        6.3.2 Pfizer Description and Business Overview
        6.3.3 Pfizer Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Pfizer Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.3.5 Pfizer Recent Developments/Updates
    6.4 Progenics Pharmaceuticals
        6.4.1 Progenics Pharmaceuticals Corporation Information
        6.4.2 Progenics Pharmaceuticals Description and Business Overview
        6.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.4.5 Progenics Pharmaceuticals Recent Developments/Updates
    6.5 Shionogi &
        6.5.1 Shionogi & Corporation Information
        6.5.2 Shionogi & Description and Business Overview
        6.5.3 Shionogi & Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Shionogi & Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.5.5 Shionogi & Recent Developments/Updates
    6.6 Allergan
        6.6.1 Allergan Corporation Information
        6.6.2 Allergan Description and Business Overview
        6.6.3 Allergan Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 Allergan Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.6.5 Allergan Recent Developments/Updates
    6.7 Nektar Therapeutics
        6.6.1 Nektar Therapeutics Corporation Information
        6.6.2 Nektar Therapeutics Description and Business Overview
        6.6.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.7.5 Nektar Therapeutics Recent Developments/Updates
    6.8 Purdue Pharma
        6.8.1 Purdue Pharma Corporation Information
        6.8.2 Purdue Pharma Description and Business Overview
        6.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.8.5 Purdue Pharma Recent Developments/Updates
    6.9 S.L.A. Pharma
        6.9.1 S.L.A. Pharma Corporation Information
        6.9.2 S.L.A. Pharma Description and Business Overview
        6.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.9.5 S.L.A. Pharma Recent Developments/Updates
    6.10 Mundipharma International Limited
        6.10.1 Mundipharma International Limited Corporation Information
        6.10.2 Mundipharma International Limited Description and Business Overview
        6.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.10.5 Mundipharma International Limited Recent Developments/Updates
    6.11 Ono Pharmaceutical
        6.11.1 Ono Pharmaceutical Corporation Information
        6.11.2 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Description and Business Overview
        6.11.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.11.4 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.11.5 Ono Pharmaceutical Recent Developments/Updates
    6.12 Takeda Pharmaceutical Company Limited
        6.12.1 Takeda Pharmaceutical Company Limited Corporation Information
        6.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Description and Business Overview
        6.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.12.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
    6.13 Theravance Biopharma
        6.13.1 Theravance Biopharma Corporation Information
        6.13.2 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Description and Business Overview
        6.13.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.13.4 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.13.5 Theravance Biopharma Recent Developments/Updates
    6.14 Bausch Health
        6.14.1 Bausch Health Corporation Information
        6.14.2 Bausch Health Opioid Induced Constipation (OIC) Drug Description and Business Overview
        6.14.3 Bausch Health Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.14.4 Bausch Health Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.14.5 Bausch Health Recent Developments/Updates
    6.15 Cosmo Pharmaceuticals SA
        6.15.1 Cosmo Pharmaceuticals SA Corporation Information
        6.15.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Description and Business Overview
        6.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.15.5 Cosmo Pharmaceuticals SA Recent Developments/Updates
    6.16 Daewoong Pharmaceutical
        6.16.1 Daewoong Pharmaceutical Corporation Information
        6.16.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Description and Business Overview
        6.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.16.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.16.5 Daewoong Pharmaceutical Recent Developments/Updates
    6.17 C.B. Fleet Company
        6.17.1 C.B. Fleet Company Corporation Information
        6.17.2 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Description and Business Overview
        6.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.17.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.17.5 C.B. Fleet Company Recent Developments/Updates
    6.18 Sucampo Pharmaceuticals
        6.18.1 Sucampo Pharmaceuticals Corporation Information
        6.18.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Description and Business Overview
        6.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2018-2023)
        6.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolio
        6.18.5 Sucampo Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
    7.1 Opioid Induced Constipation (OIC) Drug Industry Chain Analysis
    7.2 Opioid Induced Constipation (OIC) Drug Key Raw Materials
       7.2.1 Key Raw Materials
       7.2.2 Raw Materials Key Suppliers
    7.3 Opioid Induced Constipation (OIC) Drug Production Mode & Process
    7.4 Opioid Induced Constipation (OIC) Drug Sales and Marketing
        7.4.1 Opioid Induced Constipation (OIC) Drug Sales Channels
        7.4.2 Opioid Induced Constipation (OIC) Drug Distributors
    7.5 Opioid Induced Constipation (OIC) Drug Customers
8 Opioid Induced Constipation (OIC) Drug Market Dynamics
    8.1 Opioid Induced Constipation (OIC) Drug Industry Trends
    8.2 Opioid Induced Constipation (OIC) Drug Market Drivers
    8.3 Opioid Induced Constipation (OIC) Drug Market Challenges
    8.4 Opioid Induced Constipation (OIC) Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer
List of Tables
    Table 1. Global Opioid Induced Constipation (OIC) Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Opioid Induced Constipation (OIC) Drug Market Value Comparison by Distribution Channel (2023-2029) & (US$ Million)
    Table 3. Global Opioid Induced Constipation (OIC) Drug Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Opioid Induced Constipation (OIC) Drug Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Opioid Induced Constipation (OIC) Drug Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Opioid Induced Constipation (OIC) Drug Average Price (USD/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Opioid Induced Constipation (OIC) Drug, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Opioid Induced Constipation (OIC) Drug, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Opioid Induced Constipation (OIC) Drug, Product Type & Application
    Table 12. Global Key Manufacturers of Opioid Induced Constipation (OIC) Drug, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Opioid Induced Constipation (OIC) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Constipation (OIC) Drug as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Opioid Induced Constipation (OIC) Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Opioid Induced Constipation (OIC) Drug Sales by Region (2018-2023) & (K Units)
    Table 18. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2018-2023)
    Table 19. Global Opioid Induced Constipation (OIC) Drug Sales by Region (2024-2029) & (K Units)
    Table 20. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2024-2029)
    Table 21. Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2018-2023)
    Table 23. Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2024-2029)
    Table 25. North America Opioid Induced Constipation (OIC) Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2018-2023) & (K Units)
    Table 27. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2024-2029) & (K Units)
    Table 28. North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Opioid Induced Constipation (OIC) Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Opioid Induced Constipation (OIC) Drug Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Opioid Induced Constipation (OIC) Drug Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Opioid Induced Constipation (OIC) Drug Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Opioid Induced Constipation (OIC) Drug Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Opioid Induced Constipation (OIC) Drug Sales (K Units) by Type (2018-2023)
    Table 51. Global Opioid Induced Constipation (OIC) Drug Sales (K Units) by Type (2024-2029)
    Table 52. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2018-2023)
    Table 53. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2024-2029)
    Table 54. Global Opioid Induced Constipation (OIC) Drug Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Opioid Induced Constipation (OIC) Drug Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2018-2023)
    Table 57. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2024-2029)
    Table 58. Global Opioid Induced Constipation (OIC) Drug Price (USD/Unit) by Type (2018-2023)
    Table 59. Global Opioid Induced Constipation (OIC) Drug Price (USD/Unit) by Type (2024-2029)
    Table 60. Global Opioid Induced Constipation (OIC) Drug Sales (K Units) by Distribution Channel (2018-2023)
    Table 61. Global Opioid Induced Constipation (OIC) Drug Sales (K Units) by Distribution Channel (2024-2029)
    Table 62. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2018-2023)
    Table 63. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2024-2029)
    Table 64. Global Opioid Induced Constipation (OIC) Drug Revenue (US$ Million) by Distribution Channel (2018-2023)
    Table 65. Global Opioid Induced Constipation (OIC) Drug Revenue (US$ Million) by Distribution Channel (2024-2029)
    Table 66. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2018-2023)
    Table 67. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2024-2029)
    Table 68. Global Opioid Induced Constipation (OIC) Drug Price (USD/Unit) by Distribution Channel (2018-2023)
    Table 69. Global Opioid Induced Constipation (OIC) Drug Price (USD/Unit) by Distribution Channel (2024-2029)
    Table 70. Ironwood Pharmaceuticals Corporation Information
    Table 71. Ironwood Pharmaceuticals Description and Business Overview
    Table 72. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 73. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product
    Table 74. Ironwood Pharmaceuticals Recent Developments/Updates
    Table 75. Daiichi Sankyo Co Corporation Information
    Table 76. Daiichi Sankyo Co Description and Business Overview
    Table 77. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 78. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product
    Table 79. Daiichi Sankyo Co Recent Developments/Updates
    Table 80. Pfizer Corporation Information
    Table 81. Pfizer Description and Business Overview
    Table 82. Pfizer Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 83. Pfizer Opioid Induced Constipation (OIC) Drug Product
    Table 84. Pfizer Recent Developments/Updates
    Table 85. Progenics Pharmaceuticals Corporation Information
    Table 86. Progenics Pharmaceuticals Description and Business Overview
    Table 87. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 88. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product
    Table 89. Progenics Pharmaceuticals Recent Developments/Updates
    Table 90. Shionogi & Corporation Information
    Table 91. Shionogi & Description and Business Overview
    Table 92. Shionogi & Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 93. Shionogi & Opioid Induced Constipation (OIC) Drug Product
    Table 94. Shionogi & Recent Developments/Updates
    Table 95. Allergan Corporation Information
    Table 96. Allergan Description and Business Overview
    Table 97. Allergan Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 98. Allergan Opioid Induced Constipation (OIC) Drug Product
    Table 99. Allergan Recent Developments/Updates
    Table 100. Nektar Therapeutics Corporation Information
    Table 101. Nektar Therapeutics Description and Business Overview
    Table 102. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 103. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product
    Table 104. Nektar Therapeutics Recent Developments/Updates
    Table 105. Purdue Pharma Corporation Information
    Table 106. Purdue Pharma Description and Business Overview
    Table 107. Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 108. Purdue Pharma Opioid Induced Constipation (OIC) Drug Product
    Table 109. Purdue Pharma Recent Developments/Updates
    Table 110. S.L.A. Pharma Corporation Information
    Table 111. S.L.A. Pharma Description and Business Overview
    Table 112. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 113. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product
    Table 114. S.L.A. Pharma Recent Developments/Updates
    Table 115. Mundipharma International Limited Corporation Information
    Table 116. Mundipharma International Limited Description and Business Overview
    Table 117. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 118. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product
    Table 119. Mundipharma International Limited Recent Developments/Updates
    Table 120. Ono Pharmaceutical Corporation Information
    Table 121. Ono Pharmaceutical Description and Business Overview
    Table 122. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 123. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product
    Table 124. Ono Pharmaceutical Recent Developments/Updates
    Table 125. Takeda Pharmaceutical Company Limited Corporation Information
    Table 126. Takeda Pharmaceutical Company Limited Description and Business Overview
    Table 127. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 128. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product
    Table 129. Takeda Pharmaceutical Company Limited Recent Developments/Updates
    Table 130. Theravance Biopharma Corporation Information
    Table 131. Theravance Biopharma Description and Business Overview
    Table 132. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 133. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product
    Table 134. Theravance Biopharma Recent Developments/Updates
    Table 135. Bausch Health Corporation Information
    Table 136. Bausch Health Description and Business Overview
    Table 137. Bausch Health Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 138. Bausch Health Opioid Induced Constipation (OIC) Drug Product
    Table 139. Bausch Health Recent Developments/Updates
    Table 140. Cosmo Pharmaceuticals SA Corporation Information
    Table 141. Cosmo Pharmaceuticals SA Description and Business Overview
    Table 142. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 143. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product
    Table 144. Cosmo Pharmaceuticals SA Recent Developments/Updates
    Table 145. Daewoong Pharmaceutical Corporation Information
    Table 146. Daewoong Pharmaceutical Description and Business Overview
    Table 147. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 148. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product
    Table 149. Daewoong Pharmaceutical Recent Developments/Updates
    Table 150. C.B. Fleet Company Corporation Information
    Table 151. C.B. Fleet Company Description and Business Overview
    Table 152. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 153. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product
    Table 154. C.B. Fleet Company Recent Developments/Updates
    Table 155. Sucampo Pharmaceuticals Corporation Information
    Table 156. Sucampo Pharmaceuticals Description and Business Overview
    Table 157. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 158. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product
    Table 159. Sucampo Pharmaceuticals Recent Developments/Updates
    Table 160. Key Raw Materials Lists
    Table 161. Raw Materials Key Suppliers Lists
    Table 162. Opioid Induced Constipation (OIC) Drug Distributors List
    Table 163. Opioid Induced Constipation (OIC) Drug Customers List
    Table 164. Opioid Induced Constipation (OIC) Drug Market Trends
    Table 165. Opioid Induced Constipation (OIC) Drug Market Drivers
    Table 166. Opioid Induced Constipation (OIC) Drug Market Challenges
    Table 167. Opioid Induced Constipation (OIC) Drug Market Restraints
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Opioid Induced Constipation (OIC) Drug
    Figure 2. Global Opioid Induced Constipation (OIC) Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Opioid Induced Constipation (OIC) Drug Market Share by Type in 2022 & 2029
    Figure 4. Lubiprostone Product Picture
    Figure 5. Methyl Naltrexone Bromide Product Picture
    Figure 6. Naldemedine Product Picture
    Figure 7. Alvimopan Product Picture
    Figure 8. Other Product Picture
    Figure 9. Global Opioid Induced Constipation (OIC) Drug Market Value Comparison by Distribution Channel (2023-2029) & (US$ Million)
    Figure 10. Global Opioid Induced Constipation (OIC) Drug Market Share by Distribution Channel in 2022 & 2029
    Figure 11. Hospital Pharmacies
    Figure 12. Retail Pharmacies
    Figure 13. Online Pharmacies
    Figure 14. Global Opioid Induced Constipation (OIC) Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Opioid Induced Constipation (OIC) Drug Market Size (2018-2029) & (US$ Million)
    Figure 16. Global Opioid Induced Constipation (OIC) Drug Sales (2018-2029) & (K Units)
    Figure 17. Global Opioid Induced Constipation (OIC) Drug Average Price (USD/Unit) & (2018-2029)
    Figure 18. Opioid Induced Constipation (OIC) Drug Report Years Considered
    Figure 19. Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers in 2022
    Figure 20. Global Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers in 2022
    Figure 21. The Global 5 and 10 Largest Opioid Induced Constipation (OIC) Drug Players: Market Share by Revenue in 2022
    Figure 22. Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 23. Global Opioid Induced Constipation (OIC) Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 24. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2018-2029)
    Figure 25. North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2018-2029)
    Figure 26. U.S. Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 27. Canada Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2018-2029)
    Figure 29. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2018-2029)
    Figure 30. Germany Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. France Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. U.K. Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Italy Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Russia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2018-2029)
    Figure 36. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2018-2029)
    Figure 37. China Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Japan Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. South Korea Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. India Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Australia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Taiwan Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Indonesia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Thailand Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Malaysia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Philippines Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Latin America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2018-2029)
    Figure 48. Latin America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2018-2029)
    Figure 49. Mexico Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Brazil Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Argentina Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2018-2029)
    Figure 53. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2018-2029)
    Figure 54. Turkey Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. Saudi Arabia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 56. U.A.E Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 57. Global Sales Market Share of Opioid Induced Constipation (OIC) Drug by Type (2018-2029)
    Figure 58. Global Revenue Market Share of Opioid Induced Constipation (OIC) Drug by Type (2018-2029)
    Figure 59. Global Opioid Induced Constipation (OIC) Drug Price (USD/Unit) by Type (2018-2029)
    Figure 60. Global Sales Market Share of Opioid Induced Constipation (OIC) Drug by Distribution Channel (2018-2029)
    Figure 61. Global Revenue Market Share of Opioid Induced Constipation (OIC) Drug by Distribution Channel (2018-2029)
    Figure 62. Global Opioid Induced Constipation (OIC) Drug Price (USD/Unit) by Distribution Channel (2018-2029)
    Figure 63. Opioid Induced Constipation (OIC) Drug Value Chain
    Figure 64. Opioid Induced Constipation (OIC) Drug Production Process
    Figure 65. Channels of Distribution (Direct Vs Distribution)
    Figure 66. Distributors Profiles
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Ironwood Pharmaceuticals
Daiichi Sankyo Co
Pfizer
Progenics Pharmaceuticals
Shionogi &
Allergan
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma
Mundipharma International Limited
Ono Pharmaceutical
Takeda Pharmaceutical Company Limited
Theravance Biopharma
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Frequently Asked Questions
Opioid Induced Constipation (OIC) Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Opioid Induced Constipation (OIC) Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Opioid Induced Constipation (OIC) Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Orthopedic

This report aims to provide a comprehensive presentation of the global market for Orthopedic, wit ... Read More

Polylactic

This report aims to provide a comprehensive presentation of the global market for Polylactic, wit ... Read More